‌

Trogenix

Trogenix is a gene therapy platform founded in 2023 by Steve Pollard.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Health technology

Location

B2X

CEO

Founder

Number of Employees (Ranges)

1 – 10

Email Address

Investors

Cancer Research Horizons

Meltwind Advisory

Brain Tumor Investment Fund

Calculus Capital

IQ Capital Partners

...

Founded Date

2023

Total Funding Amount (USD)

95,000,000

Latest Funding Round Date

October 6, 2025

CTO

Juan Manuel Iglesias

CFO

Mark Collingbourne

Latest Funding Type

Country

Headquarters

Other attributes

Latest Funding Round Amount (USD)

95,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Trogenix

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.